Kindred At Home | |
3107 Clearwater Drive, Suite A, Prescott, Arizona 86305 | |
(928) 445-2522 | |
Name | Kindred At Home |
---|---|
Location | 3107 Clearwater Drive, Suite A, Prescott, Arizona |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 37139 |
Ownership Type | Proprietary |
Service Area Zip Codes | 86301, 86303, 86305, 86314, 86315, 86322, 86323, 86324, 86325, 86326, 86327, 86331, 86333, 86334, 86335, 86336, 86341, 86351 |
NPI Number | 1437158821 |
Organization Name | CENTERWELL CERTIFIED HEALTHCARE CORP |
Doing Business As | CENTERWELL HOME HEALTH |
Address | 3107 Clearwater Dr, Suite A, Prescott, AZ 86305 |
Phone Number | 928-445-2522 |
News Archive
Venaxis, Inc., an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1 Test, a rapid, multiple biomarker-based assay for identifying patients that are at low risk for appendicitis, today announced completion of patient enrollment in its pivotal clinical study of the APPY1 Test in the United States.
"Oregon's hospital spending boom is winding to a close," as hospitals cut back on projects, Portland Business Journal reports. "Portland-area hospitals have opened, started construction on, or announced expansions costing at least $1.3 billion in the past 18 months. Projects include cancer treatment centers, cardiac units and pediatric care facilities.
Al Jazeera examines how Iraq's public health system has been affected by the war and the challenges doctors in the country currently face. Iraq had 34,000 registered physicians before the U.S.-led invasion in 2003, and it is estimated that 20,000 of them have left the country, according to the Brookings Institution.
The metabolic enzyme IL4I1 (Interleukin-4-Induced-1) promotes the spread of tumor cells and suppresses the immune system.
New research sheds light on common pathogenic mechanisms shared by Huntington's disease (HD) and HD-like disorders. The study, published by Cell Press in the May 12, 2011, issue of the journal Neuron, uses a new transgenic mouse model for an HD-like disorder to unravel complex molecular events that drive disease pathology.
› Verified 3 days ago
Quality Rating: |
News Archive
Venaxis, Inc., an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1 Test, a rapid, multiple biomarker-based assay for identifying patients that are at low risk for appendicitis, today announced completion of patient enrollment in its pivotal clinical study of the APPY1 Test in the United States.
"Oregon's hospital spending boom is winding to a close," as hospitals cut back on projects, Portland Business Journal reports. "Portland-area hospitals have opened, started construction on, or announced expansions costing at least $1.3 billion in the past 18 months. Projects include cancer treatment centers, cardiac units and pediatric care facilities.
Al Jazeera examines how Iraq's public health system has been affected by the war and the challenges doctors in the country currently face. Iraq had 34,000 registered physicians before the U.S.-led invasion in 2003, and it is estimated that 20,000 of them have left the country, according to the Brookings Institution.
The metabolic enzyme IL4I1 (Interleukin-4-Induced-1) promotes the spread of tumor cells and suppresses the immune system.
New research sheds light on common pathogenic mechanisms shared by Huntington's disease (HD) and HD-like disorders. The study, published by Cell Press in the May 12, 2011, issue of the journal Neuron, uses a new transgenic mouse model for an HD-like disorder to unravel complex molecular events that drive disease pathology.
› Verified 3 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 99.3 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 99.6 | 98.6 |
How often the home health team checked patients’ risk of falling | 100 | 99.6 |
How often the home health team checked patients for depression | 100 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 81.9 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 80.2 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 93.1 | 96.4 |
News Archive
Venaxis, Inc., an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1 Test, a rapid, multiple biomarker-based assay for identifying patients that are at low risk for appendicitis, today announced completion of patient enrollment in its pivotal clinical study of the APPY1 Test in the United States.
"Oregon's hospital spending boom is winding to a close," as hospitals cut back on projects, Portland Business Journal reports. "Portland-area hospitals have opened, started construction on, or announced expansions costing at least $1.3 billion in the past 18 months. Projects include cancer treatment centers, cardiac units and pediatric care facilities.
Al Jazeera examines how Iraq's public health system has been affected by the war and the challenges doctors in the country currently face. Iraq had 34,000 registered physicians before the U.S.-led invasion in 2003, and it is estimated that 20,000 of them have left the country, according to the Brookings Institution.
The metabolic enzyme IL4I1 (Interleukin-4-Induced-1) promotes the spread of tumor cells and suppresses the immune system.
New research sheds light on common pathogenic mechanisms shared by Huntington's disease (HD) and HD-like disorders. The study, published by Cell Press in the May 12, 2011, issue of the journal Neuron, uses a new transgenic mouse model for an HD-like disorder to unravel complex molecular events that drive disease pathology.
› Verified 3 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 84.5 | 79.6 |
How often patients got better at getting in and out of bed | 84.4 | 81.1 |
How often patients got better at bathing | 86.3 | 82.3 |
How often patients’ breathing improved | 86.9 | 82.8 |
How often patients’ wounds improved or healed after an operation | 97.6 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 79.7 | 75 |
How often home health patients had to be admitted to the hospital | 12 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 13.5 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 91.8 | 94 |
News Archive
Venaxis, Inc., an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1 Test, a rapid, multiple biomarker-based assay for identifying patients that are at low risk for appendicitis, today announced completion of patient enrollment in its pivotal clinical study of the APPY1 Test in the United States.
"Oregon's hospital spending boom is winding to a close," as hospitals cut back on projects, Portland Business Journal reports. "Portland-area hospitals have opened, started construction on, or announced expansions costing at least $1.3 billion in the past 18 months. Projects include cancer treatment centers, cardiac units and pediatric care facilities.
Al Jazeera examines how Iraq's public health system has been affected by the war and the challenges doctors in the country currently face. Iraq had 34,000 registered physicians before the U.S.-led invasion in 2003, and it is estimated that 20,000 of them have left the country, according to the Brookings Institution.
The metabolic enzyme IL4I1 (Interleukin-4-Induced-1) promotes the spread of tumor cells and suppresses the immune system.
New research sheds light on common pathogenic mechanisms shared by Huntington's disease (HD) and HD-like disorders. The study, published by Cell Press in the May 12, 2011, issue of the journal Neuron, uses a new transgenic mouse model for an HD-like disorder to unravel complex molecular events that drive disease pathology.
› Verified 3 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
Venaxis, Inc., an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1 Test, a rapid, multiple biomarker-based assay for identifying patients that are at low risk for appendicitis, today announced completion of patient enrollment in its pivotal clinical study of the APPY1 Test in the United States.
"Oregon's hospital spending boom is winding to a close," as hospitals cut back on projects, Portland Business Journal reports. "Portland-area hospitals have opened, started construction on, or announced expansions costing at least $1.3 billion in the past 18 months. Projects include cancer treatment centers, cardiac units and pediatric care facilities.
Al Jazeera examines how Iraq's public health system has been affected by the war and the challenges doctors in the country currently face. Iraq had 34,000 registered physicians before the U.S.-led invasion in 2003, and it is estimated that 20,000 of them have left the country, according to the Brookings Institution.
The metabolic enzyme IL4I1 (Interleukin-4-Induced-1) promotes the spread of tumor cells and suppresses the immune system.
New research sheds light on common pathogenic mechanisms shared by Huntington's disease (HD) and HD-like disorders. The study, published by Cell Press in the May 12, 2011, issue of the journal Neuron, uses a new transgenic mouse model for an HD-like disorder to unravel complex molecular events that drive disease pathology.
› Verified 3 days ago
The patient survey data of Kindred At Home is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 86 | 88 |
Percent of patients who reported that their home health team communicated well with them | 83 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 78 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 79 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 78 | 78 |
News Archive
Venaxis, Inc., an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1 Test, a rapid, multiple biomarker-based assay for identifying patients that are at low risk for appendicitis, today announced completion of patient enrollment in its pivotal clinical study of the APPY1 Test in the United States.
"Oregon's hospital spending boom is winding to a close," as hospitals cut back on projects, Portland Business Journal reports. "Portland-area hospitals have opened, started construction on, or announced expansions costing at least $1.3 billion in the past 18 months. Projects include cancer treatment centers, cardiac units and pediatric care facilities.
Al Jazeera examines how Iraq's public health system has been affected by the war and the challenges doctors in the country currently face. Iraq had 34,000 registered physicians before the U.S.-led invasion in 2003, and it is estimated that 20,000 of them have left the country, according to the Brookings Institution.
The metabolic enzyme IL4I1 (Interleukin-4-Induced-1) promotes the spread of tumor cells and suppresses the immune system.
New research sheds light on common pathogenic mechanisms shared by Huntington's disease (HD) and HD-like disorders. The study, published by Cell Press in the May 12, 2011, issue of the journal Neuron, uses a new transgenic mouse model for an HD-like disorder to unravel complex molecular events that drive disease pathology.
› Verified 3 days ago
Bayada Home Health Care, Inc. Location: 2971 Willow Creek Road, Building 1, Suite A, Prescott, Arizona 86301 Ratings: Phone: (928) 759-5900 | |
Kindred At Home Location: 3107 Clearwater Drive, Suite A, Prescott, Arizona 86305 Ratings: Phone: (928) 445-2522 | |
Good Samaritan Society - Legacy Home Care Location: 1953 Commerce Circle, Prescott, Arizona 86301 Ratings: Phone: (928) 443-9331 |